This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Identification
- Generic Name
- Sodium cation
- DrugBank Accession Number
- DB14516
- Background
Not Available
- Type
- Small Molecule
- Groups
- Experimental
- Structure
Structure for Sodium cation (DB14516)
- Weight
- Average: 22.9898
Monoisotopic: 22.989769675 - Chemical Formula
- Na
- Synonyms
- Sodium (ion)
- Sodium ion
- sodium(1+)
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
Avoid life-threatening adverse drug eventsImprove clinical decision support with information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events & improve clinical decision support.- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates.Improve decision support & research outcomes with our structured adverse effects data.- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Drug Interaction Integrate drug-drug
interactions in your softwareAcetazolamide The risk or severity of dehydration can be increased when Acetazolamide is combined with Sodium cation. Aclidinium The therapeutic efficacy of Sodium cation can be decreased when used in combination with Aclidinium. Alfentanil The therapeutic efficacy of Sodium cation can be decreased when used in combination with Alfentanil. Alloin The risk or severity of adverse effects can be increased when Sodium cation is combined with Alloin. Almasilate The therapeutic efficacy of Sodium cation can be decreased when used in combination with Almasilate. Aluminium phosphate The therapeutic efficacy of Sodium cation can be decreased when used in combination with Aluminium phosphate. Aluminum hydroxide The therapeutic efficacy of Sodium cation can be decreased when used in combination with Aluminum hydroxide. Amantadine The therapeutic efficacy of Sodium cation can be decreased when used in combination with Amantadine. Amiloride The risk or severity of dehydration can be increased when Amiloride is combined with Sodium cation. Amiodarone The therapeutic efficacy of Sodium cation can be decreased when used in combination with Amiodarone. 
Identify potential medication risksEasily compare up to 40 drugs with our drug interaction checker.Get severity rating, description, and management advice.Learn more - Food Interactions
- Not Available
Products
Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions.- Mixture Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image Acetolyt - Granulat Sodium cation (7.5 mmol) + Calcium (7.5 mmol) + Citric acid (8.75 mmol) Granule, for solution Oral Medicopharm Gmb H 1972-09-15 Not applicable Austria 
ASIDOPAN PLUS 200 ML SUSPANSIYON Sodium cation (1 mg/5ml) + Magaldrate (540 mg/5ml) + Simethicone (20 mg/5ml) Suspension Oral TURGUT İLAÇLARI A.Ş. 2020-08-14 Not applicable Turkey 
ASIDOPAN PLUS 60 CIGNEME TABLET Sodium cation (1 mg) + Magaldrate (480 mg) + Simethicone (20 mg) Tablet, chewable Oral TURGUT İLAÇLARI A.Ş. 2020-08-14 Not applicable Turkey GNC Prima-C 1000 Timed Release Sodium cation (15 mg) + Ascorbic acid (1000 mg) + Calcium (6 mg) + Citrus bioflavonoids (50 mg) Tablet, delayed release Oral ONI Global (Malaysia) Sdn Bhd 2020-09-08 Not applicable Malaysia 
NUTRIFLEX LIPID PERI INFUZYONLUK IV EMULSIYON, 1870 ML Sodium cation (75 mmol) + Acetate (60 mmol) + Alanine (7.28 g) + Arginine (4.05 g) + Aspartic acid (2.25 g) + Calcium (4.5 mmol) + Calcium chloride dihydrate (0.662 g) + Chlorine (72 mmol) + D-glucose (120 g) + Glutamic acid (5.25 g) + Glycine (2.48 g) + Histidine (1.88 g) + Isoleucine (3.51 g) + Leucine (4.7 g) + Lysine (3.39 g) + Magnesium (4.5 mmol) + Magnesium acetate tetrahydrate (0.966 g) + Medium-chain triglycerides (37.5 g) + Methionine (2.94 g) + Phenylalanine (5.27 g) + Potassium (45 mmol) + Potassium acetate (4.415 g) + Proline (5.1 g) + Serine (4.5 g) + Sodium acetate trihydrate (0.816 g) + Sodium chloride (1.622 g) + Sodium hydroxide (1.2 g) + Sodium phosphate, monobasic, dihydrate (1.755 g) + Soybean oil (37.5 g) + Threonine (2.73 g) + Tryptophan (0.86 g) + Valine (3.9 g) + Zinc (0.045 mmol) + Zinc acetate dihydrate (9.938 mg) Injection, emulsion Intravenous B.BRAUN MEDİKAL DIŞ TİC. A.Ş. 2020-08-14 2018-10-12 Turkey NUTRIFLEX LIPID PERI INFUZYONLUK IV EMULSIYON, 2500 ML Sodium cation (100 mmol) + Acetate (80 mmol) + Alanine (9.7 g) + Arginine (5.4 g) + Aspartic acid (3 g) + Calcium (6 mmol) + Calcium chloride dihydrate (0.882 g) + Chlorine (96 mmol) + D-glucose (160 g) + Glutamic acid (7 g) + Glycine (3.3 g) + Histidine (2.5 g) + Isoleucine (4.68 g) + Leucine (6.26 g) + Lysine (4.52 g) + Magnesium (6 mmol) + Magnesium acetate tetrahydrate (1.288 g) + Medium-chain triglycerides (50 g) + Methionine (3.92 g) + Phenylalanine (7.02 g) + Potassium (60 mmol) + Potassium acetate (5.886 g) + Proline (6.8 g) + Serine (6 g) + Sodium acetate trihydrate (1.088 g) + Sodium chloride (2.162 g) + Sodium hydroxide (1.6 g) + Sodium phosphate, monobasic, dihydrate (2.34 g) + Soybean oil (50 g) + Threonine (3.64 g) + Tryptophan (1.14 g) + Valine (5.2 g) + Zinc (0.06 mmol) + Zinc acetate dihydrate (13.25 mg) Injection, emulsion Intravenous B.BRAUN MEDİKAL DIŞ TİC. A.Ş. 2020-08-14 2018-10-12 Turkey NUTRIFLEX LIPID PLUS INFUZYONLUK EMULSIYON, 1250 ML Sodium cation (50 mmol) + Acetate (45 mmol) + Alanine (5.82 g) + Arginine (3.24 g) + Aspartic acid (1.8 g) + Calcium (4 mmol) + Calcium chloride dihydrate (0.588 g) + Chlorine (45 mmol) + D-glucose (150 g) + Glutamic acid (4.21 g) + Glycine (1.98 g) + Histidine (1.5 g) + Isoleucine (2.82 g) + Leucine (3.76 g) + Lysine (2.73 g) + Magnesium (4 mmol) + Magnesium acetate tetrahydrate (0.858 g) + Medium-chain triglycerides (25 g) + Methionine (2.35 g) + Phenylalanine (4.21 g) + Phosphate ion (15 mmol) + Potassium (35 mmol) + Potassium acetate (3.434 g) + Proline (4.08 g) + Serine (3.6 g) + Sodium acetate trihydrate (0.277 g) + Sodium chloride (0.503 g) + Sodium hydroxide (0.976 g) + Sodium phosphate, monobasic, dihydrate (2.34 g) + Soybean oil (25 g) + Threonine (2.18 g) + Tryptophan (0.68 g) + Valine (3.12 g) + Zinc (0.03 mmol) + Zinc acetate dihydrate (6.58 mg) Injection, emulsion Intravenous B.BRAUN MEDİKAL DIŞ TİC. A.Ş. 2020-08-14 2018-10-03 Turkey NUTRIFLEX LIPID PLUS INFUZYONLUK EMULSIYON, 1870 ML Sodium cation (75 mmol) + Acetate (67.5 mmol) + Alanine (8.73 g) + Arginine (4.86 g) + Aspartic acid (2.7 g) + Calcium (6 mmol) + Calcium chloride dihydrate (0.882 g) + Chlorine (67.5 mmol) + D-glucose (225 g) + Glutamic acid (6.32 g) + Glycine (2.97 g) + Histidine (2.25 g) + Isoleucine (4.23 g) + Leucine (5.64 g) + Lysine (4.1 g) + Magnesium (6 mmol) + Magnesium acetate tetrahydrate (1.287 g) + Medium-chain triglycerides (37.5 g) + Methionine (3.53 g) + Phenylalanine (6.32 g) + Phosphate ion (22.5 mmol) + Potassium (52.5 mmol) + Potassium acetate (5.151 g) + Proline (6.12 g) + Serine (5.4 g) + Sodium acetate trihydrate (0.416 g) + Sodium chloride (0.755 g) + Sodium hydroxide (1.464 g) + Sodium phosphate, monobasic, dihydrate (3.51 g) + Soybean oil (37.5 g) + Threonine (3.27 g) + Tryptophan (1.02 g) + Valine (4.68 g) + Zinc (0.045 mmol) + Zinc acetate dihydrate (9.87 mg) Injection, emulsion Intravenous B.BRAUN MEDİKAL DIŞ TİC. A.Ş. 2020-08-14 2018-10-03 Turkey NUTRIFLEX LIPID PLUS INFUZYONLUK EMULSIYON, 2500 ML Sodium cation (100 mmol) + Acetate (90 mmol) + Alanine (11.64 g) + Arginine (6.48 g) + Aspartic acid (3.6 g) + Calcium (8 mmol) + Calcium chloride dihydrate (1.176 g) + Chlorine (90 mmol) + D-glucose (300 g) + Glutamic acid (8.42 g) + Glycine (3.96 g) + Histidine (3 g) + Isoleucine (5.64 g) + Leucine (7.52 g) + Lysine (5.46 g) + Magnesium (8 mmol) + Magnesium acetate tetrahydrate (1.716 g) + Medium-chain triglycerides (50 g) + Methionine (4.7 g) + Phenylalanine (8.42 g) + Phosphate ion (30 mmol) + Potassium (70 mmol) + Potassium acetate (6.868 g) + Proline (8.16 g) + Serine (7.2 g) + Sodium acetate trihydrate (0.554 g) + Sodium chloride (1.006 g) + Sodium hydroxide (1.952 g) + Sodium phosphate, monobasic, dihydrate (4.68 g) + Soybean oil (50 g) + Threonine (4.36 g) + Tryptophan (1.36 g) + Valine (6.24 g) + Zinc (0.06 mmol) + Zinc acetate dihydrate (13.16 mg) Injection, emulsion Intravenous B.BRAUN MEDİKAL DIŞ TİC. A.Ş. 2020-08-14 2018-10-03 Turkey NUTRIFLEX LIPID SPECIAL INTRAVENOZ INFUZYONLUK EMULSIYON, 1250 ML Sodium cation (50 mmol) + Acetate (45 mmol) + Alanine (5.82 g) + Arginine (3.24 g) + Aspartic acid (1.8 g) + Calcium (4 mmol) + Calcium chloride dihydrate (0.588 g) + Chlorine (45 mmol) + D-glucose (150 g) + Glutamic acid (4.21 g) + Glutamic acid (1.98 g) + Histidine (2.03 g) + Isoleucine (2.82 g) + Leucine (3.76 g) + Lysine (2.73 g) + Magnesium (4 mmol) + Magnesium acetate tetrahydrate (0.858 g) + Medium-chain triglycerides (25 g) + Methionine (2.35 g) + Phenylalanine (4.21 g) + Phosphate ion (15 mmol) + Potassium (35 mmol) + Potassium acetate (3.434 g) + Proline (4.08 g) + Serine (3.6 g) + Sodium acetate trihydrate (0.277 g) + Sodium chloride (0.503 g) + Sodium hydroxide (0.976 g) + Sodium phosphate, monobasic, dihydrate (2.34 g) + Soybean oil (25 g) + Threonine (2.18 g) + Tryptophan (0.68 g) + Valine (3.12 g) + Zinc (0.03 mmol) + Zinc acetate dihydrate (6.58 mg) Emulsion Intravenous B.BRAUN MEDİKAL DIŞ TİC. A.Ş. 2020-08-14 2018-10-03 Turkey - Unapproved/Other Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image NinePercent Sodium cation (90 g/1000g) Injection, solution Intravenous US Specialty Formulations LLC 2014-12-01 Not applicable US 
Categories
- Drug Categories
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- LYR4M0NH37
- CAS number
- 17341-25-2
- InChI Key
- FKNQFGJONOIPTF-UHFFFAOYSA-N
- InChI
- InChI=1S/Na/q+1
- IUPAC Name
- sodium(1+) ion
- SMILES
- [Na+]
References
- General References
- Not Available
- External Links
- PDB Entries
- 131d / 191d / 192d / 193l / 194l / 1a2c / 1a3d / 1a46 / 1a4w / 1a50 … show 11164 more
Clinical Trials
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
Form Route Strength Granule, for solution Oral Injection, solution Intravenous Suspension Oral Tablet, chewable Oral Injection, powder, for solution Intravenous Tablet, delayed release Oral Injection, solution Intravenous 90 g/1000g Injection, emulsion Intravenous Emulsion Intravenous Solution Intraperitoneal Solution Intravenous Solution Intravenous 100.000 mL Solution Intravenous 50.000 mL - Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
- Predicted Properties
Property Value Source logP -0.77 Chemaxon pKa (Strongest Acidic) 3.09 Chemaxon Physiological Charge 1 Chemaxon Hydrogen Acceptor Count 0 Chemaxon Hydrogen Donor Count 0 Chemaxon Polar Surface Area 0 Å2 Chemaxon Rotatable Bond Count 0 Chemaxon Refractivity 0 m3·mol-1 Chemaxon Polarizability 1.78 Å3 Chemaxon Number of Rings 0 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter No Chemaxon Veber's Rule Yes Chemaxon MDDR-like Rule No Chemaxon - Predicted ADMET Features
- Not Available
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
Drug created at July 12, 2018 16:35 / Updated at June 17, 2022 22:42